157 related articles for article (PubMed ID: 11039425)
1. Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage.
Hesse L; Schroeder B; Heller G; Kroll P
Retina; 2000; 20(5):500-5. PubMed ID: 11039425
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome.
Schulze SD; Hesse L
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):717-20. PubMed ID: 12271367
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
Hay SR; Madonna RJ
Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
[TBL] [Abstract][Full Text] [Related]
4. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas.
Hesse L; Schmidt J; Kroll P
Graefes Arch Clin Exp Ophthalmol; 1999 Apr; 237(4):273-7. PubMed ID: 10208258
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
Krepler K; Kruger A; Tittl M; Stur M; Wedrich A
Retina; 2000; 20(3):251-6. PubMed ID: 10872929
[TBL] [Abstract][Full Text] [Related]
6. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
Fassbender JM; Sherman MP; Barr CC; Schaal S
Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
[TBL] [Abstract][Full Text] [Related]
7. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
Handwerger BA; Blodi BA; Chandra SR; Olsen TW; Stevens TS
Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.
Meyer CH; Scholl HP; Eter N; Helb HM; Holz FG
Acta Ophthalmol; 2008 Aug; 86(5):490-4. PubMed ID: 18221499
[TBL] [Abstract][Full Text] [Related]
9. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
Hassan AS; Johnson MW; Schneiderman TE; Regillo CD; Tornambe PE; Poliner LS; Blodi BA; Elner SG
Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
[TBL] [Abstract][Full Text] [Related]
10. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
[TBL] [Abstract][Full Text] [Related]
11. [Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection].
Meier P; Zeumer C; Jochmann C; Wiedemann P
Ophthalmologe; 1999 Oct; 96(10):643-7. PubMed ID: 10552156
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas.
Hesse L; Kroll P
Adv Ther; 1997; 14(5):275-80. PubMed ID: 10174620
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
Lincoff H; Kreissig I
Retina; 2001; 21(2):191. PubMed ID: 11321154
[No Abstract] [Full Text] [Related]
14. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.
Hattenbach LO; Klais C; Koch FH; Gümbel HO
Ophthalmology; 2001 Aug; 108(8):1485-92. PubMed ID: 11470706
[TBL] [Abstract][Full Text] [Related]
15. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator.
Ohji M; Saito Y; Hayashi A; Lewis JM; Tano Y
Arch Ophthalmol; 1998 Oct; 116(10):1326-32. PubMed ID: 9790631
[TBL] [Abstract][Full Text] [Related]
16. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
Hillenkamp J; Surguch V; Framme C; Gabel VP; Sachs HG
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):5-11. PubMed ID: 19669780
[TBL] [Abstract][Full Text] [Related]
17. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
Chen CY; Hooper C; Chiu D; Chamberlain M; Karia N; Heriot WJ
Retina; 2007 Mar; 27(3):321-8. PubMed ID: 17460587
[TBL] [Abstract][Full Text] [Related]
18. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
Mizutani T; Yasukawa T; Ito Y; Takase A; Hirano Y; Yoshida M; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1153-7. PubMed ID: 21445629
[TBL] [Abstract][Full Text] [Related]
19. tPA and gas in submacular hemorrhage.
Lewis H
Ophthalmology; 2002 May; 109(5):824; author reply 825. PubMed ID: 11986071
[No Abstract] [Full Text] [Related]
20. [Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].
Framme C; Toukhy HE; Sachs HG; Spiegel D; Roider J; Gabel VP; Lohmann CP
Klin Monbl Augenheilkd; 2000 Jan; 216(1):33-9. PubMed ID: 10702940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
